Abstract:The success of gene therapy depends largely on the efficacy of gene delivery vector systems that can deliver genes to target organs or cells selectively and efficiently with minimal toxicity. Here, we show that by using the HRE.ppET-1 regulatory element, we were able to restrict expression of the transgene of vascular endothelial growth factor (VEGF) to endothelial cells exclusively in hypoxic conditions. Eukaryotic expression vectors such as pEGFP-HRE.ppET-1, pcDNA3.1-VEGF+Pa, pcDNA3.1-ppET-1+ EGF+Pa, and pcDNA3.1-HRE.ppET-1+VEGF+Pa were constructed by using a series of nuclear molecule handling methods like PCR, enzyme digestion. The recombinant vectors were transfected into HUVEC cells and HL7702 cells by the lipofectin method. GFP expression was observed with a fluorescence microscope to validate the specificity of expression in endothelial cells under the regulation of HRE.ppET-1 element. Cobalt chloride (final concentration 100 μmol/L) was added to the medium to mimic hypoxia in vitro. After transfection of vectors, the expression of VEGF mRNA was detected by RT-PCR, and the expression of VEGF was detected by Western blotting and ELISA methods under normoxia and hypoxia, respectively. The cell proliferation rate was detected by the MTT test. The expression of GFP revealed that the exterior gene was transcripted effectively in endothelial cells regulated by the HRE.ppET-1 element, while the expression of GFP was very weak in nonendothelial cells. The results of RT-PCR, Western blotting and ELISA showed that VEGF gene expression in the pcDNA3.1-HRE.ppET-1+VEGF+Pa group and in the pcDNA3.1-ppET-1+VEGF+Pa group was higher in hypoxia than it was in normoxia (P<0.05). The MTT test showed that the proliferation rate of HUVEC transfected with HPVA under hypoxia exceeded that of the control group. We conclude that the HRE.ppET-1 element was expressed specifically in endothelial cells, and can increase the expression of VEGF in hypoxia and stimulate proliferation of endothelial cells. Taking advantage of these facts could greatly improve the efficiency of gene therapy. The vector would be valuable for various gene transfer studies targeting endothelial cells.

The Targeting Expression of the Vascular Endothelial Growth Factor Gene in Endothelial Cells Regulated by HRE.ppET-1

Directing Endothelial Differentiation of Human Embryonic Stem Cells Via Transduction with an Adenoviral Vector Expressing the VEGF165 Gene

Construction of vector specifically expressed vascular endothelial growth factor gene in endothelial cells and research of its expressive character

Reiterated Targeting Peptides on the Nanoparticle Surface Significantly Promote Targeted Vascular Endothelial Growth Factor Gene Delivery to Stem Cells.

Construction and verification of a hypoxia-induced gene therapy vector targeting hepatocellular carcinoma

The Effect of HRE-Regulated VEGF Expression and Transfection on Neural Stem Cells in Rats.

Angiogenesis Effect on Rat Liver after Administration of Expression Vector Encoding Vascular Endothelial Growth Factor D

Development of a hypoxia-responsive vector for tumor-specific gene therapy

Development of Endothelial-Specific Single Inducible Lentiviral Vectors for Genetic Engineering of Endothelial Progenitor Cells

Promotive effect of polytetrafluoroethylene vascular grafts carrying VEGF gene on the growth of endothelial cells

Hypoxia-responsive Elements Enhancing the Toxicity of HSVtk-mediated Gene-Directed Enzyme Prodrug Therapy in Lung Cancer Cells Induced by Hypoxia

Expression of vascular endothelial growth factor in endothelial progenitor cells following its expression vector construction

[Application of Polytetrafluoroethylene As VEGF Gene Carrier].

Hypoxic Response Elements and Tet-On Advanced Double-Controlled Systems Regulate Hvegf165 and Angiopoietin-1 Gene Expression in Vitro

Exploitation of Hypoxia Regulatory Vectors for Gene Therapy of Renal Anemia

Adeno-associated Viral Vector-Mediated Hypoxia-Regulated VEGF Gene Transfer Promotes Angiogenesis Following Focal Cerebral Ischemia in Mice

In Vivo Enhancement Of Angiogenesis By Adenoviral Transfer Of Hif-1 Alpha-Modified Endothelial Progenitor Cells (Ad-Hif-1 Alpha-Modified Epc For Angiogenesis)

Expression of Human Vascular Endothelial Growth Factor in Cultured NIH3T3 Cells

Feasibility of Hypoxia Inducible Factor Gene Transfer in Endothelial Progenitor Cell for Vascular Regeneration

Hypoxic Inducible Factor 1α Gene Regulated Human Endothelial Progenitor Cells from Peripheral Blood in Hypoxia

Angiogenesis by Transplantation of HIF-1 Alpha Modified EPCs into Ischemic Limbs.